The International Association for the Study of Lung Cancer (IASLC) shared a post on X:
“Help shape how patient experiences are measured in lung cancer research!
IASLC invites you to review and share feedback on consensus statements about patient-reported outcomes (PROMs) in early-stage and radically treated lung cancer trials.
Narjust Florez, Co-Director of Young Lung Cancer Program at Dana-Farber Cancer Institute, shared this post, adding:
“Help us improve patient-reported outcomes for early-stage lung cancer. It will not take you more than 10 mins!”
More posts from IASLC.